Circadian variation in coronary stent thrombosis

Karim D Mahmoud1, Ryan J Lennon, Henry H Ting

  • 1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA.

Insights

Coronary stent thrombosis peaks around 7:00 am, particularly in early cases, and occurs more frequently during summer months. Weekly variations were not significant.

Area of Science:

  • Cardiology
  • Circadian Rhythms
  • Medical Statistics

Background:

  • Adverse cardiovascular events like myocardial infarction show diurnal, weekly, and seasonal patterns.
  • Understanding temporal variations in stent thrombosis is crucial for patient care.

Purpose of the Study:

  • To investigate the circadian, weekly, and seasonal variations in the occurrence of coronary stent thrombosis.
  • To identify specific time patterns associated with early, late, and very late stent thrombosis.

Main Methods:

  • Analysis of 124 patients with confirmed stent thrombosis from the Mayo Clinic Percutaneous Coronary Intervention Registry.
  • Correlation of symptom onset date and time with circadian, weekly, and seasonal patterns.
  • Subgroup analysis for early (0-30 days), late (31-360 days), and very late (>360 days) stent thrombosis.

Main Results:

  • A significant circadian variation in stent thrombosis onset was observed, peaking around 7:00 am (p = 0.006).
  • Early stent thrombosis (0-30 days) showed a significant circadian pattern (p = 0.030), but late and very late thrombosis did not.
  • A significant seasonal pattern was identified, with higher incidence in summer (p = 0.036), while no weekly association was found (p = 0.509).

Conclusions:

  • Coronary stent thrombosis exhibits a circadian rhythm, with a peak incidence in the early morning (around 7:00 am), especially for early stent thrombosis.
  • The day of the week did not influence the occurrence of stent thrombosis.
  • Stent thrombosis is more likely to occur during summer months, suggesting a seasonal influence.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...